Literature DB >> 21150205

Laboratory paradigms of impulsivity and alcohol dependence: a review.

M Aragues1, R Jurado, R Quinto, G Rubio.   

Abstract

Impulsivity can be defined as choosing a smaller, immediate reward over a larger, delayed reward. From this perspective, addictive behaviors such as substance abuse and pathological gambling reflect a series of impulsive choices. However, impulsivity is not a homogeneous construct. Laboratory measures of impulsivity reflect two types of processes. The first is related to behavioral inhibition and refers to an individual's ability to appropriately inhibit thoughts or actions. The second is the delay of reward dimension, namely the degree to which immediate (rewarding) consequences have more control over an individual's behavior than consequences that are delayed. In this review, we describe how alcohol is associated with significant impairments in these paradigms. We also suggest that they may have a role in the development of alcohol dependence. These results are in agreement with a model in which delay of gratification might be a marker for early use and/or abuse of alcohol, whereas impairment in behavioral inhibition might be a marker for maintained use in time and, therefore, for progression towards alcohol dependence.
Copyright © 2010 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2010        PMID: 21150205     DOI: 10.1159/000321345

Source DB:  PubMed          Journal:  Eur Addict Res        ISSN: 1022-6877            Impact factor:   3.015


  16 in total

1.  Dimensions of impulsivity among heavy drinkers, smokers, and heavy drinking smokers: singular and combined effects.

Authors:  Nathasha R Moallem; Lara A Ray
Journal:  Addict Behav       Date:  2012-03-14       Impact factor: 3.913

Review 2.  Individual differences and social influences on the neurobehavioral pharmacology of abused drugs.

Authors:  M T Bardo; J L Neisewander; T H Kelly
Journal:  Pharmacol Rev       Date:  2013-01-23       Impact factor: 25.468

3.  Compulsivity and Impulsivity in Pathological Gambling: Does a Dimensional-Transdiagnostic Approach Add Clinical Utility to DSM-5 Classification?

Authors:  Gioia Bottesi; Marta Ghisi; Allison J Ouimet; Michael D Tira; Ezio Sanavio
Journal:  J Gambl Stud       Date:  2015-09

4.  Quetiapine improves response inhibition in alcohol dependent patients: a placebo-controlled pilot study.

Authors:  Nathasha Moallem; Lara A Ray
Journal:  Pharmacol Biochem Behav       Date:  2011-10-20       Impact factor: 3.533

5.  Impaired Recognition and Regulation of Disgust Is Associated with Distinct but Partially Overlapping Patterns of Decreased Gray Matter Volume in the Ventroanterior Insula.

Authors:  Josh D Woolley; Eric V Strobl; Virginia E Sturm; Tal Shany-Ur; Pardis Poorzand; Scott Grossman; Lauren Nguyen; Janet A Eckart; Robert W Levenson; William W Seeley; Bruce L Miller; Katherine P Rankin
Journal:  Biol Psychiatry       Date:  2015-02-07       Impact factor: 13.382

6.  Daily associations between emotional functioning and alcohol involvement: Moderating effects of response inhibition and gender.

Authors:  Robert D Dvorak; Matthew R Pearson; Emily M Sargent; Brittany L Stevenson; Angel M Mfon
Journal:  Drug Alcohol Depend       Date:  2016-06-01       Impact factor: 4.492

7.  Alcohol increases impulsivity and abuse liability in heavy drinking women.

Authors:  Stephanie Collins Reed; Frances R Levin; Suzette M Evans
Journal:  Exp Clin Psychopharmacol       Date:  2012-10-15       Impact factor: 3.157

8.  Dissociable effects of kappa-opioid receptor activation on impulsive phenotypes in wistar rats.

Authors:  Brendan M Walker; Jessica L Kissler
Journal:  Neuropsychopharmacology       Date:  2013-05-21       Impact factor: 7.853

9.  The effects of oral d-amphetamine on impulsivity in smoked and intranasal cocaine users.

Authors:  Stephanie Collins Reed; Suzette M Evans
Journal:  Drug Alcohol Depend       Date:  2016-04-19       Impact factor: 4.492

10.  Rapid decision-making under risk.

Authors:  Robert Adam; Paul M Bays; Masud Husain
Journal:  Cogn Neurosci       Date:  2011-10-12       Impact factor: 3.065

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.